Trends in the management of atrial fibrillation: A neurologist's perspective

Cardiac embolism, primarily from atrial fibrillation (AF), is implicated in a quarter of all ischemic strokes. In the setting of AF, contraindications to traditional therapies can create a clinical dilemma when choosing an agent for secondary stroke prophylaxis. Newer horizons in the medical and sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedna, Vishnumurthy Shushrutha, Favilla, Christopher G, Guerrero, Waldo R, Patel, Akhil, Gottipati, Amareshwari, Bidari, Sharathchandra, Beaver, Thomas, Waters, Michael F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516003/
https://www.ncbi.nlm.nih.gov/pubmed/23233767
http://dx.doi.org/10.4103/0975-3583.102690
Descripción
Sumario:Cardiac embolism, primarily from atrial fibrillation (AF), is implicated in a quarter of all ischemic strokes. In the setting of AF, contraindications to traditional therapies can create a clinical dilemma when choosing an agent for secondary stroke prophylaxis. Newer horizons in the medical and surgical management of AF have helped us choose from a wide variety of available therapies, the best possible management. In this article, we review the current trends in AF management including newer oral anticoagulants as well as surgical devices from a neurologist's view.

Ejemplares similares